Clinical Trials on PRETEXT II Hepatoblastoma in Korea, Republic of
Total 265 results
-
National Cancer Institute (NCI)Active, not recruitingPRETEXT I Hepatoblastoma | PRETEXT II Hepatoblastoma | PRETEXT III Hepatoblastoma | PRETEXT IV HepatoblastomaUnited States, Canada, Puerto Rico, Australia, Japan, Brazil
-
AstraZenecaCompletedStage II HypertensionKorea, Republic of
-
Seoul National University HospitalRecruitingPreterm InfantsKorea, Republic of
-
Seoul National University HospitalCompletedPreterm LaborKorea, Republic of
-
Seoul National University HospitalCompletedInfant, PretermKorea, Republic of
-
Seoul National University HospitalAjou University School of Medicine; Severance HospitalCompletedInfant, PretermKorea, Republic of
-
Seoul National University HospitalCompletedPreterm Labor | Preterm Premature Rupture of Membrane (PPROM)Korea, Republic of
-
Yonsei UniversityCompletedEpilepsy and Focal Cortical Dysplasia IIKorea, Republic of
-
Seoul National University HospitalAsan Medical Center; Severance HospitalEnrolling by invitation
-
Seoul National University HospitalAjou University School of Medicine; DongGuk UniversityTerminatedPreterm Infants | Mechanical Ventilator CareKorea, Republic of
-
Pusan National University HospitalPusan National University Yangsan HospitalUnknownElective Surgery of Gastrointestinal Tract | 100 Adults Aged Between 20 and 70 Years Old | ASA Physical Status of I or IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalUnknownType II DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Seoul National University HospitalCompletedPreterm Infants | Gastrointestinal RefluxKorea, Republic of
-
Korea University Anam HospitalAstraZenecaUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType II Diabetes MellitusKorea, Republic of
-
Yonsei UniversityCompleted
-
BayerCompleted
-
Yonsei UniversityActive, not recruitingLarynx | Stage II-IVB Operable HNSCC Oral Cavity | Hypopharynx | OropharynxKorea, Republic of
-
Hallym University Kangnam Sacred Heart HospitalCompletedIn the Present Study, we Investigated the Effects of Oral Ambroxol on Tear Film and Ocular Surface.Korea, Republic of
-
HucircadianPusan National University Hospital; Korea University Guro Hospital; Korea University... and other collaboratorsRecruitingMajor Depressive Disorder | Bipolar 1 Disorder | Bipolar II DisorderKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.CompletedDyslipidemia | Type II DiabetesKorea, Republic of
-
Seoul National University HospitalSeoul National University Bundang HospitalCompleted
-
Boryung Pharmaceutical Co., LtdRecruitingStage II Colon Cancer | Stage III Colon CancerKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyMerck Ltd.CompletedHypertension | Diabetes Mellitus, Type IIKorea, Republic of
-
Inha University HospitalCompletedPreterm Infants | Respiratory Distress Syndrome In Premature InfantsKorea, Republic of
-
Seoul National University HospitalRotaryCompletedNoninvasive Neurally Adjusted Ventilatory Assist and Pressure Support in Preterm InfantsKorea, Republic of
-
Yonsei UniversityRecruitingPotentially Resectable Stage II/IIIa NSCLCKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownBreast Cancer Stage II | Breast Cancer Stage IIIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Seoul National University HospitalUnknownProstate Cancer Recurrent | Stage II Prostate Carcinoma | Stage III Prostate CarcinomaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
Samsung Medical CenterTerminatedPhase I: To Determine the Maximum Tolerated Dose (MTD) | Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/OxaliplatinKorea, Republic of
-
Samsung Medical CenterCompletedPreterm Premature Rupture of the MembranesKorea, Republic of
-
Yonsei UniversityUnknownNon-DM Stage II High-risk Colorectal Cancer | Non-DM Stage III Colorectal CancerKorea, Republic of
-
Samsung Medical CenterCompletedPreterm Premature Rupture of MembraneKorea, Republic of
-
Samsung Medical CenterUnknownNasophayngeal Carcinoma Between Stage II and IVbKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type IIKorea, Republic of
-
Yuhan CorporationCompletedDyslipidemia | Type II DiabetesKorea, Republic of